nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A7—Irinotecan—colon cancer	0.135	0.175	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.135	0.175	CbGbCtD
Eplerenone—CYP3A7—Vincristine—colon cancer	0.118	0.153	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.118	0.153	CbGbCtD
Eplerenone—CYP3A5—Irinotecan—colon cancer	0.101	0.132	CbGbCtD
Eplerenone—CYP3A5—Vincristine—colon cancer	0.0884	0.115	CbGbCtD
Eplerenone—CYP3A4—Irinotecan—colon cancer	0.0394	0.0513	CbGbCtD
Eplerenone—CYP3A4—Vincristine—colon cancer	0.0345	0.0448	CbGbCtD
Eplerenone—Myocardial infarction—Vincristine—colon cancer	0.00107	0.00465	CcSEcCtD
Eplerenone—Pneumonia—Irinotecan—colon cancer	0.00107	0.00465	CcSEcCtD
Eplerenone—Protein urine present—Methotrexate—colon cancer	0.00106	0.00462	CcSEcCtD
Eplerenone—Diabetes mellitus—Capecitabine—colon cancer	0.00106	0.00462	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00106	0.00462	CcSEcCtD
Eplerenone—Acute coronary syndrome—Irinotecan—colon cancer	0.00105	0.00456	CcSEcCtD
Eplerenone—Renal failure—Irinotecan—colon cancer	0.00104	0.00454	CcSEcCtD
Eplerenone—Myocardial infarction—Irinotecan—colon cancer	0.00104	0.00453	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00104	0.00453	CcSEcCtD
Eplerenone—Pneumonia—Fluorouracil—colon cancer	0.00102	0.00445	CcSEcCtD
Eplerenone—Hyperuricaemia—Methotrexate—colon cancer	0.00102	0.00444	CcSEcCtD
Eplerenone—Infestation NOS—Fluorouracil—colon cancer	0.00102	0.00443	CcSEcCtD
Eplerenone—Infestation—Fluorouracil—colon cancer	0.00102	0.00443	CcSEcCtD
Eplerenone—Acute coronary syndrome—Fluorouracil—colon cancer	0.001	0.00436	CcSEcCtD
Eplerenone—Myocardial infarction—Fluorouracil—colon cancer	0.000997	0.00434	CcSEcCtD
Eplerenone—Neuropathy peripheral—Fluorouracil—colon cancer	0.000997	0.00434	CcSEcCtD
Eplerenone—Libido decreased—Capecitabine—colon cancer	0.000994	0.00433	CcSEcCtD
Eplerenone—Urinary tract infection—Fluorouracil—colon cancer	0.000988	0.0043	CcSEcCtD
Eplerenone—Hypoaesthesia—Vincristine—colon cancer	0.000974	0.00424	CcSEcCtD
Eplerenone—Atrial fibrillation—Capecitabine—colon cancer	0.000973	0.00424	CcSEcCtD
Eplerenone—Renal impairment—Capecitabine—colon cancer	0.000969	0.00422	CcSEcCtD
Eplerenone—Urinary tract disorder—Vincristine—colon cancer	0.000966	0.00421	CcSEcCtD
Eplerenone—Blood uric acid increased—Methotrexate—colon cancer	0.000963	0.00419	CcSEcCtD
Eplerenone—Connective tissue disorder—Vincristine—colon cancer	0.000962	0.00419	CcSEcCtD
Eplerenone—Urethral disorder—Vincristine—colon cancer	0.000959	0.00418	CcSEcCtD
Eplerenone—Connective tissue disorder—Irinotecan—colon cancer	0.000936	0.00408	CcSEcCtD
Eplerenone—Hyponatraemia—Capecitabine—colon cancer	0.000926	0.00403	CcSEcCtD
Eplerenone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000915	0.00398	CcSEcCtD
Eplerenone—Cardiac disorder—Vincristine—colon cancer	0.000908	0.00395	CcSEcCtD
Eplerenone—Hypoaesthesia—Fluorouracil—colon cancer	0.000908	0.00395	CcSEcCtD
Eplerenone—Pharyngitis—Fluorouracil—colon cancer	0.000906	0.00395	CcSEcCtD
Eplerenone—Angiopathy—Vincristine—colon cancer	0.000888	0.00387	CcSEcCtD
Eplerenone—Flushing—Irinotecan—colon cancer	0.000884	0.00385	CcSEcCtD
Eplerenone—Cardiac disorder—Irinotecan—colon cancer	0.000884	0.00385	CcSEcCtD
Eplerenone—Mediastinal disorder—Vincristine—colon cancer	0.000882	0.00384	CcSEcCtD
Eplerenone—Angiopathy—Irinotecan—colon cancer	0.000865	0.00377	CcSEcCtD
Eplerenone—Blood creatinine increased—Capecitabine—colon cancer	0.000864	0.00376	CcSEcCtD
Eplerenone—Mediastinal disorder—Irinotecan—colon cancer	0.000859	0.00374	CcSEcCtD
Eplerenone—Dehydration—Capecitabine—colon cancer	0.000857	0.00373	CcSEcCtD
Eplerenone—Mental disorder—Vincristine—colon cancer	0.000857	0.00373	CcSEcCtD
Eplerenone—Gynaecomastia—Methotrexate—colon cancer	0.000846	0.00368	CcSEcCtD
Eplerenone—Orthostatic hypotension—Capecitabine—colon cancer	0.000842	0.00367	CcSEcCtD
Eplerenone—Pulmonary oedema—Methotrexate—colon cancer	0.000842	0.00367	CcSEcCtD
Eplerenone—Hypokalaemia—Capecitabine—colon cancer	0.000839	0.00365	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00083	0.00362	CcSEcCtD
Eplerenone—Back pain—Vincristine—colon cancer	0.000824	0.00359	CcSEcCtD
Eplerenone—Flatulence—Irinotecan—colon cancer	0.000817	0.00356	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000813	0.00354	CcSEcCtD
Eplerenone—Back pain—Irinotecan—colon cancer	0.000802	0.00349	CcSEcCtD
Eplerenone—Muscle spasms—Irinotecan—colon cancer	0.000798	0.00347	CcSEcCtD
Eplerenone—Diabetes mellitus—Methotrexate—colon cancer	0.000789	0.00344	CcSEcCtD
Eplerenone—Anaemia—Vincristine—colon cancer	0.000787	0.00343	CcSEcCtD
Eplerenone—Angina pectoris—Capecitabine—colon cancer	0.000776	0.00338	CcSEcCtD
Eplerenone—Ill-defined disorder—Irinotecan—colon cancer	0.00077	0.00335	CcSEcCtD
Eplerenone—Anaemia—Irinotecan—colon cancer	0.000767	0.00334	CcSEcCtD
Eplerenone—Bronchitis—Capecitabine—colon cancer	0.000766	0.00334	CcSEcCtD
Eplerenone—Drospirenone—PTGS2—colon cancer	0.000756	0.378	CrCbGaD
Eplerenone—Malaise—Irinotecan—colon cancer	0.000748	0.00326	CcSEcCtD
Eplerenone—Syncope—Irinotecan—colon cancer	0.000744	0.00324	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Capecitabine—colon cancer	0.000741	0.00323	CcSEcCtD
Eplerenone—Anaemia—Fluorouracil—colon cancer	0.000734	0.0032	CcSEcCtD
Eplerenone—Loss of consciousness—Irinotecan—colon cancer	0.000729	0.00318	CcSEcCtD
Eplerenone—Myalgia—Vincristine—colon cancer	0.000725	0.00316	CcSEcCtD
Eplerenone—Cough—Irinotecan—colon cancer	0.000724	0.00315	CcSEcCtD
Eplerenone—Hyperglycaemia—Capecitabine—colon cancer	0.000719	0.00313	CcSEcCtD
Eplerenone—Pneumonia—Capecitabine—colon cancer	0.000715	0.00311	CcSEcCtD
Eplerenone—Infestation NOS—Capecitabine—colon cancer	0.00071	0.00309	CcSEcCtD
Eplerenone—Infestation—Capecitabine—colon cancer	0.00071	0.00309	CcSEcCtD
Eplerenone—Depression—Capecitabine—colon cancer	0.000708	0.00309	CcSEcCtD
Eplerenone—Acute coronary syndrome—Capecitabine—colon cancer	0.0007	0.00305	CcSEcCtD
Eplerenone—Renal failure—Capecitabine—colon cancer	0.000698	0.00304	CcSEcCtD
Eplerenone—Discomfort—Irinotecan—colon cancer	0.000698	0.00304	CcSEcCtD
Eplerenone—Myocardial infarction—Capecitabine—colon cancer	0.000696	0.00303	CcSEcCtD
Eplerenone—Neuropathy peripheral—Capecitabine—colon cancer	0.000696	0.00303	CcSEcCtD
Eplerenone—Infection—Vincristine—colon cancer	0.000691	0.00301	CcSEcCtD
Eplerenone—Urinary tract infection—Capecitabine—colon cancer	0.000691	0.00301	CcSEcCtD
Eplerenone—Nervous system disorder—Vincristine—colon cancer	0.000682	0.00297	CcSEcCtD
Eplerenone—Haematuria—Capecitabine—colon cancer	0.000677	0.00295	CcSEcCtD
Eplerenone—Chest pain—Fluorouracil—colon cancer	0.000676	0.00295	CcSEcCtD
Eplerenone—Myalgia—Fluorouracil—colon cancer	0.000676	0.00295	CcSEcCtD
Eplerenone—Infection—Irinotecan—colon cancer	0.000673	0.00293	CcSEcCtD
Eplerenone—Hyperhidrosis—Vincristine—colon cancer	0.000672	0.00293	CcSEcCtD
Eplerenone—Hepatobiliary disease—Capecitabine—colon cancer	0.000672	0.00293	CcSEcCtD
Eplerenone—Discomfort—Fluorouracil—colon cancer	0.000668	0.00291	CcSEcCtD
Eplerenone—Shock—Irinotecan—colon cancer	0.000666	0.0029	CcSEcCtD
Eplerenone—Nervous system disorder—Irinotecan—colon cancer	0.000664	0.00289	CcSEcCtD
Eplerenone—Hyperhidrosis—Irinotecan—colon cancer	0.000655	0.00285	CcSEcCtD
Eplerenone—Hypotension—Vincristine—colon cancer	0.00065	0.00283	CcSEcCtD
Eplerenone—Infection—Fluorouracil—colon cancer	0.000644	0.00281	CcSEcCtD
Eplerenone—Nervous system disorder—Fluorouracil—colon cancer	0.000636	0.00277	CcSEcCtD
Eplerenone—Hypoaesthesia—Capecitabine—colon cancer	0.000635	0.00276	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000633	0.00276	CcSEcCtD
Eplerenone—Pharyngitis—Capecitabine—colon cancer	0.000633	0.00276	CcSEcCtD
Eplerenone—Hypotension—Irinotecan—colon cancer	0.000633	0.00276	CcSEcCtD
Eplerenone—Urinary tract disorder—Capecitabine—colon cancer	0.00063	0.00274	CcSEcCtD
Eplerenone—Insomnia—Vincristine—colon cancer	0.000629	0.00274	CcSEcCtD
Eplerenone—Oedema peripheral—Capecitabine—colon cancer	0.000628	0.00274	CcSEcCtD
Eplerenone—Connective tissue disorder—Capecitabine—colon cancer	0.000627	0.00273	CcSEcCtD
Eplerenone—Urethral disorder—Capecitabine—colon cancer	0.000625	0.00272	CcSEcCtD
Eplerenone—Insomnia—Irinotecan—colon cancer	0.000612	0.00267	CcSEcCtD
Eplerenone—Hypotension—Fluorouracil—colon cancer	0.000606	0.00264	CcSEcCtD
Eplerenone—Dyspnoea—Irinotecan—colon cancer	0.000604	0.00263	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Vincristine—colon cancer	0.0006	0.00261	CcSEcCtD
Eplerenone—Fatigue—Vincristine—colon cancer	0.000599	0.00261	CcSEcCtD
Eplerenone—Dyspepsia—Irinotecan—colon cancer	0.000596	0.0026	CcSEcCtD
Eplerenone—Tinnitus—Capecitabine—colon cancer	0.000595	0.00259	CcSEcCtD
Eplerenone—Constipation—Vincristine—colon cancer	0.000594	0.00259	CcSEcCtD
Eplerenone—Pain—Vincristine—colon cancer	0.000594	0.00259	CcSEcCtD
Eplerenone—Flushing—Capecitabine—colon cancer	0.000592	0.00258	CcSEcCtD
Eplerenone—Cardiac disorder—Capecitabine—colon cancer	0.000592	0.00258	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000591	0.00257	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—colon cancer	0.000587	0.00256	CcSEcCtD
Eplerenone—Insomnia—Fluorouracil—colon cancer	0.000586	0.00255	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000585	0.00255	CcSEcCtD
Eplerenone—Fatigue—Irinotecan—colon cancer	0.000584	0.00254	CcSEcCtD
Eplerenone—Constipation—Irinotecan—colon cancer	0.000579	0.00252	CcSEcCtD
Eplerenone—Pain—Irinotecan—colon cancer	0.000579	0.00252	CcSEcCtD
Eplerenone—Angiopathy—Capecitabine—colon cancer	0.000579	0.00252	CcSEcCtD
Eplerenone—Dyspnoea—Fluorouracil—colon cancer	0.000578	0.00252	CcSEcCtD
Eplerenone—Mediastinal disorder—Capecitabine—colon cancer	0.000575	0.0025	CcSEcCtD
Eplerenone—Dyspepsia—Fluorouracil—colon cancer	0.000571	0.00249	CcSEcCtD
Eplerenone—Gastrointestinal pain—Vincristine—colon cancer	0.000568	0.00248	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00056	0.00244	CcSEcCtD
Eplerenone—Mental disorder—Capecitabine—colon cancer	0.000559	0.00243	CcSEcCtD
Eplerenone—Feeling abnormal—Irinotecan—colon cancer	0.000558	0.00243	CcSEcCtD
Eplerenone—Malnutrition—Capecitabine—colon cancer	0.000555	0.00242	CcSEcCtD
Eplerenone—Pain—Fluorouracil—colon cancer	0.000555	0.00241	CcSEcCtD
Eplerenone—Gastrointestinal pain—Irinotecan—colon cancer	0.000554	0.00241	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000551	0.0024	CcSEcCtD
Eplerenone—Abdominal pain—Vincristine—colon cancer	0.00055	0.00239	CcSEcCtD
Eplerenone—Body temperature increased—Vincristine—colon cancer	0.00055	0.00239	CcSEcCtD
Eplerenone—Flatulence—Capecitabine—colon cancer	0.000547	0.00238	CcSEcCtD
Eplerenone—Back pain—Capecitabine—colon cancer	0.000537	0.00234	CcSEcCtD
Eplerenone—Abdominal pain—Irinotecan—colon cancer	0.000535	0.00233	CcSEcCtD
Eplerenone—Body temperature increased—Irinotecan—colon cancer	0.000535	0.00233	CcSEcCtD
Eplerenone—Feeling abnormal—Fluorouracil—colon cancer	0.000534	0.00233	CcSEcCtD
Eplerenone—Muscle spasms—Capecitabine—colon cancer	0.000534	0.00232	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—colon cancer	0.000532	0.00232	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—colon cancer	0.000529	0.0023	CcSEcCtD
Eplerenone—Infestation—Methotrexate—colon cancer	0.000529	0.0023	CcSEcCtD
Eplerenone—Depression—Methotrexate—colon cancer	0.000527	0.0023	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—colon cancer	0.00052	0.00226	CcSEcCtD
Eplerenone—Ill-defined disorder—Capecitabine—colon cancer	0.000515	0.00224	CcSEcCtD
Eplerenone—Anaemia—Capecitabine—colon cancer	0.000513	0.00223	CcSEcCtD
Eplerenone—Body temperature increased—Fluorouracil—colon cancer	0.000513	0.00223	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—colon cancer	0.000504	0.0022	CcSEcCtD
Eplerenone—Malaise—Capecitabine—colon cancer	0.000501	0.00218	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—colon cancer	0.0005	0.00218	CcSEcCtD
Eplerenone—Asthenia—Vincristine—colon cancer	0.000499	0.00217	CcSEcCtD
Eplerenone—Syncope—Capecitabine—colon cancer	0.000498	0.00217	CcSEcCtD
Eplerenone—Loss of consciousness—Capecitabine—colon cancer	0.000488	0.00213	CcSEcCtD
Eplerenone—Asthenia—Irinotecan—colon cancer	0.000486	0.00212	CcSEcCtD
Eplerenone—Cough—Capecitabine—colon cancer	0.000484	0.00211	CcSEcCtD
Eplerenone—Diarrhoea—Vincristine—colon cancer	0.000476	0.00207	CcSEcCtD
Eplerenone—Arthralgia—Capecitabine—colon cancer	0.000473	0.00206	CcSEcCtD
Eplerenone—Myalgia—Capecitabine—colon cancer	0.000473	0.00206	CcSEcCtD
Eplerenone—Chest pain—Capecitabine—colon cancer	0.000473	0.00206	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—colon cancer	0.000471	0.00205	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000469	0.00204	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—colon cancer	0.000469	0.00204	CcSEcCtD
Eplerenone—Discomfort—Capecitabine—colon cancer	0.000467	0.00203	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—colon cancer	0.000465	0.00203	CcSEcCtD
Eplerenone—Diarrhoea—Irinotecan—colon cancer	0.000463	0.00202	CcSEcCtD
Eplerenone—Dizziness—Vincristine—colon cancer	0.00046	0.002	CcSEcCtD
Eplerenone—Pruritus—Fluorouracil—colon cancer	0.000459	0.002	CcSEcCtD
Eplerenone—Spironolactone—ABCB1—colon cancer	0.000458	0.229	CrCbGaD
Eplerenone—Infection—Capecitabine—colon cancer	0.00045	0.00196	CcSEcCtD
Eplerenone—Dizziness—Irinotecan—colon cancer	0.000448	0.00195	CcSEcCtD
Eplerenone—Shock—Capecitabine—colon cancer	0.000446	0.00194	CcSEcCtD
Eplerenone—Nervous system disorder—Capecitabine—colon cancer	0.000444	0.00194	CcSEcCtD
Eplerenone—Diarrhoea—Fluorouracil—colon cancer	0.000444	0.00193	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—colon cancer	0.000443	0.00193	CcSEcCtD
Eplerenone—Vomiting—Vincristine—colon cancer	0.000442	0.00192	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—colon cancer	0.000441	0.00192	CcSEcCtD
Eplerenone—Skin disorder—Capecitabine—colon cancer	0.00044	0.00192	CcSEcCtD
Eplerenone—Rash—Vincristine—colon cancer	0.000438	0.00191	CcSEcCtD
Eplerenone—Hyperhidrosis—Capecitabine—colon cancer	0.000438	0.00191	CcSEcCtD
Eplerenone—Dermatitis—Vincristine—colon cancer	0.000438	0.00191	CcSEcCtD
Eplerenone—Headache—Vincristine—colon cancer	0.000436	0.0019	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—colon cancer	0.000431	0.00188	CcSEcCtD
Eplerenone—Vomiting—Irinotecan—colon cancer	0.00043	0.00187	CcSEcCtD
Eplerenone—Dizziness—Fluorouracil—colon cancer	0.000429	0.00187	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—colon cancer	0.000428	0.00186	CcSEcCtD
Eplerenone—Rash—Irinotecan—colon cancer	0.000427	0.00186	CcSEcCtD
Eplerenone—Dermatitis—Irinotecan—colon cancer	0.000426	0.00186	CcSEcCtD
Eplerenone—Headache—Irinotecan—colon cancer	0.000424	0.00185	CcSEcCtD
Eplerenone—Hypotension—Capecitabine—colon cancer	0.000423	0.00184	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—colon cancer	0.000416	0.00181	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—colon cancer	0.000413	0.0018	CcSEcCtD
Eplerenone—Nausea—Vincristine—colon cancer	0.000413	0.0018	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000413	0.0018	CcSEcCtD
Eplerenone—Vomiting—Fluorouracil—colon cancer	0.000412	0.0018	CcSEcCtD
Eplerenone—Insomnia—Capecitabine—colon cancer	0.00041	0.00178	CcSEcCtD
Eplerenone—Rash—Fluorouracil—colon cancer	0.000409	0.00178	CcSEcCtD
Eplerenone—Dermatitis—Fluorouracil—colon cancer	0.000408	0.00178	CcSEcCtD
Eplerenone—Headache—Fluorouracil—colon cancer	0.000406	0.00177	CcSEcCtD
Eplerenone—Dyspnoea—Capecitabine—colon cancer	0.000404	0.00176	CcSEcCtD
Eplerenone—Nausea—Irinotecan—colon cancer	0.000402	0.00175	CcSEcCtD
Eplerenone—Back pain—Methotrexate—colon cancer	0.0004	0.00174	CcSEcCtD
Eplerenone—Dyspepsia—Capecitabine—colon cancer	0.000399	0.00174	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000391	0.0017	CcSEcCtD
Eplerenone—Fatigue—Capecitabine—colon cancer	0.000391	0.0017	CcSEcCtD
Eplerenone—Pain—Capecitabine—colon cancer	0.000387	0.00169	CcSEcCtD
Eplerenone—Constipation—Capecitabine—colon cancer	0.000387	0.00169	CcSEcCtD
Eplerenone—Nausea—Fluorouracil—colon cancer	0.000385	0.00168	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—colon cancer	0.000383	0.00167	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—colon cancer	0.000382	0.00166	CcSEcCtD
Eplerenone—Feeling abnormal—Capecitabine—colon cancer	0.000373	0.00163	CcSEcCtD
Eplerenone—Malaise—Methotrexate—colon cancer	0.000373	0.00162	CcSEcCtD
Eplerenone—Gastrointestinal pain—Capecitabine—colon cancer	0.000371	0.00161	CcSEcCtD
Eplerenone—Cough—Methotrexate—colon cancer	0.000361	0.00157	CcSEcCtD
Eplerenone—Abdominal pain—Capecitabine—colon cancer	0.000358	0.00156	CcSEcCtD
Eplerenone—Body temperature increased—Capecitabine—colon cancer	0.000358	0.00156	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—colon cancer	0.000352	0.00153	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—colon cancer	0.000352	0.00153	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—colon cancer	0.000352	0.00153	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000349	0.00152	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—colon cancer	0.000348	0.00151	CcSEcCtD
Eplerenone—Infection—Methotrexate—colon cancer	0.000335	0.00146	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—colon cancer	0.000331	0.00144	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—colon cancer	0.000328	0.00143	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—colon cancer	0.000326	0.00142	CcSEcCtD
Eplerenone—Asthenia—Capecitabine—colon cancer	0.000325	0.00142	CcSEcCtD
Eplerenone—Pruritus—Capecitabine—colon cancer	0.000321	0.0014	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—colon cancer	0.000315	0.00137	CcSEcCtD
Eplerenone—Diarrhoea—Capecitabine—colon cancer	0.00031	0.00135	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000307	0.00134	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—colon cancer	0.000305	0.00133	CcSEcCtD
Eplerenone—Hydrocortisone—ABCB1—colon cancer	0.000304	0.152	CrCbGaD
Eplerenone—Dyspnoea—Methotrexate—colon cancer	0.000301	0.00131	CcSEcCtD
Eplerenone—Dizziness—Capecitabine—colon cancer	0.0003	0.0013	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—colon cancer	0.000297	0.00129	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000291	0.00127	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—colon cancer	0.000291	0.00127	CcSEcCtD
Eplerenone—Pain—Methotrexate—colon cancer	0.000288	0.00126	CcSEcCtD
Eplerenone—Vomiting—Capecitabine—colon cancer	0.000288	0.00125	CcSEcCtD
Eplerenone—Rash—Capecitabine—colon cancer	0.000286	0.00124	CcSEcCtD
Eplerenone—Dermatitis—Capecitabine—colon cancer	0.000285	0.00124	CcSEcCtD
Eplerenone—Headache—Capecitabine—colon cancer	0.000284	0.00124	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—colon cancer	0.000278	0.00121	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—colon cancer	0.000276	0.0012	CcSEcCtD
Eplerenone—Nausea—Capecitabine—colon cancer	0.000269	0.00117	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—colon cancer	0.000267	0.00116	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—colon cancer	0.000267	0.00116	CcSEcCtD
Eplerenone—Progesterone—ABCB1—colon cancer	0.000248	0.124	CrCbGaD
Eplerenone—Asthenia—Methotrexate—colon cancer	0.000242	0.00105	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—colon cancer	0.000239	0.00104	CcSEcCtD
Eplerenone—Testosterone—ABCB1—colon cancer	0.000234	0.117	CrCbGaD
Eplerenone—Diarrhoea—Methotrexate—colon cancer	0.000231	0.00101	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—colon cancer	0.000223	0.000971	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—colon cancer	0.000214	0.000934	CcSEcCtD
Eplerenone—Rash—Methotrexate—colon cancer	0.000213	0.000926	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—colon cancer	0.000212	0.000925	CcSEcCtD
Eplerenone—Headache—Methotrexate—colon cancer	0.000211	0.00092	CcSEcCtD
Eplerenone—Nausea—Methotrexate—colon cancer	0.0002	0.000873	CcSEcCtD
